Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, Kotb Abdelmohsen, Akihisa Abe, +2329

Autophagy

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky, Fábio Camargo Abdalla, Hagai Abeliovich, +1232

Autophagy

MitophagyParticular Autophagy AssaysImmunologyCytoskeletonMultiple Assays +17

The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity.

Anthony W. Opipari, Hong‐Ming Hu, R Yabkowitz, +1

Journal of Biological Chemistry

InflammationA20 MessageCytokineApoptosisImmunology +9

The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B.

Carol D. Laherty, Hong‐Ming Hu, Anthony W. Opipari, +2

Journal of Biological Chemistry

Transcriptional RegulationMolecular VirologyEpstein-barr VirusViral ImmunityViral Pathogenesis +13

Blockade of the Phagocytic Receptor MerTK on Tumor-Associated Macrophages Enhances P2X7R-Dependent STING Activation by Tumor-Derived cGAMP

Yi Zhou, Mingjian Fei, Gu Zhang, +25

Immunity

InflammationPhagocytic Receptor MertkCytokineMedicineImmunology +8

A novel RING finger protein interacts with the cytoplasmic domain of CD40.

Hong‐Ming Hu, Karen O’Rourke, Mark S. Boguski, +1

Journal of Biological Chemistry

Protein FunctionSignal TransductionSignaling PathwayNatural SciencesCytoplasmic Domain +11

Alpha-alumina nanoparticles induce efficient autophagy-dependent cross-presentation and potent antitumour response

Haiyan Li, Yuhuan Li, Jun Jiao, +1

Nature Nanotechnology

Drug TargetingNanotherapeuticsMedicineTumor TargetingAlpha-alumina Nanoparticles +3

Efficient Cross-presentation Depends on Autophagy in Tumor Cells

Yuhuan Li, Lixin Wang, Guojun Yang, +3

Cancer Research

Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity

Huiming Chen, William van der Touw, Yuan Shuo Wang, +16

Journal of Clinical Investigation

Adjuvant Therapy With Agonistic Antibodies to CD134 (OX40) Increases Local Control After Surgical or Radiation Therapy of Cancer in Mice

Michael J. Gough, Marka R. Crittenden, Maryclare Sarff, +7

Journal of Immunotherapy

Surgical OncologyTumor RecurrenceImmunologyPathologyImmunotherapeutics +19